Activated cAbl1 induces phosphorylation of VEGFR2 at Y951, promoting receptor retention at the EC surface which in a sustained manner induces Rac1 activity and EC migration and tumor angiogenesis (Figure 1). The gene discussed is ABL1; the disease is neoplasm.